MCM
CLBT icon

MAI Capital Management’s Cellebrite CLBT Stock Holding History

MAI Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-622
Closed -$8.57K – 2560
2026
Q1 		$8.57K Buy
+622
New +$9.37K ﹤0.01% 3240
2025
Q4 		– Sell
-76
Closed -$1.41K – 4378
2025
Q3 		$1.41K Buy
+76
New +$1.19K ﹤0.01% 3398

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MAI Capital Management's CLBT Position: Q2 2026 in Review

MAI Capital Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 622 shares — an estimated $8.57K sold.

MAI Capital Management first reported a position in CLBT in Q3 2025 and held it in 2 quarters. The position peaked at $8.57K in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • MAI Capital Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 622 Cellebrite shares in Q2 2026, an estimated $8.57K.
  • MAI Capital Management first reported a position in Cellebrite in Q3 2025 and held it in 2 quarters.
  • MAI Capital Management's Cellebrite position peaked at $8.57K in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.